Page last updated: 2024-10-30

meclofenamic acid and Local Neoplasm Recurrence

meclofenamic acid has been researched along with Local Neoplasm Recurrence in 2 studies

Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.

Research Excerpts

ExcerptRelevanceReference
"Glioblastoma is the most frequent and malignant primary brain tumor."7.11Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. ( Becker, A; Burger, MC; Clusmann, H; Delev, D; Giordano, FA; Glas, M; Goldbrunner, R; Grauer, O; Güresir, E; Hau, P; Heiland, DH; Herrlinger, U; Krex, D; Nemeth, R; Potthoff, AL; Radbruch, A; Sabel, M; Schaub, C; Schilling, J; Schlegel, U; Schmid, M; Schneider, M; Schnell, O; Schuss, P; Seidel, C; Steinbach, JP; Tabatabai, G; Thon, N; Vatter, H; Weller, J; Winkler, F; Zeyen, T, 2022)
"Glioblastoma is the most frequent and malignant primary brain tumor."3.11Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial. ( Becker, A; Burger, MC; Clusmann, H; Delev, D; Giordano, FA; Glas, M; Goldbrunner, R; Grauer, O; Güresir, E; Hau, P; Heiland, DH; Herrlinger, U; Krex, D; Nemeth, R; Potthoff, AL; Radbruch, A; Sabel, M; Schaub, C; Schilling, J; Schlegel, U; Schmid, M; Schneider, M; Schnell, O; Schuss, P; Seidel, C; Steinbach, JP; Tabatabai, G; Thon, N; Vatter, H; Weller, J; Winkler, F; Zeyen, T, 2022)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Zeyen, T1
Potthoff, AL1
Nemeth, R1
Heiland, DH1
Burger, MC1
Steinbach, JP1
Hau, P1
Tabatabai, G1
Glas, M1
Schlegel, U1
Grauer, O1
Krex, D1
Schnell, O1
Goldbrunner, R1
Sabel, M1
Thon, N1
Delev, D1
Clusmann, H1
Seidel, C1
Güresir, E1
Schmid, M1
Schuss, P1
Giordano, FA1
Radbruch, A1
Becker, A1
Weller, J1
Schaub, C1
Vatter, H1
Schilling, J1
Winkler, F1
Herrlinger, U1
Schneider, M1
Yanar, S1
Kasap, M1
Kanli, A1
Akpinar, G1
Sarihan, M1

Trials

1 trial available for meclofenamic acid and Local Neoplasm Recurrence

ArticleYear
Phase I/II trial of meclofenamate in progressive MGMT-methylated glioblastoma under temozolomide second-line therapy-the MecMeth/NOA-24 trial.
    Trials, 2022, Jan-19, Volume: 23, Issue:1

    Topics: Antineoplastic Agents, Alkylating; DNA Modification Methylases; DNA Repair Enzymes; Glioblastoma; Hu

2022

Other Studies

1 other study available for meclofenamic acid and Local Neoplasm Recurrence

ArticleYear
Proteomics analysis of meclofenamic acid-treated small cell lung carcinoma cells revealed changes in cellular energy metabolism for cancer cell survival.
    Journal of biochemical and molecular toxicology, 2023, Volume: 37, Issue:4

    Topics: Cell Line, Tumor; Cell Survival; Chromatography, Liquid; Glycolysis; Humans; Lung Neoplasms; Meclofe

2023